µ¿¹ÝÁø´ÜÀ» Àü¹®À¸·Î ´Ù·ç´Â ÷´Ü ¿°»ö°ú ¸ÖƼ¿À¹Í½º ±â´ÉÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁø
¼¼°è Á¶Á÷ Áø´Ü ½ÃÀåÀº ¸ÂÃãÇü ÀÇ·á¿¡¼ Á¤È®ÇÑ ¹ÙÀÌ¿À¸¶Ä¿ ½Äº°À» À§ÇÑ °í±Þ ¿°»öÀÇ Çʿ伺, Á¶Á÷ »ý°ËÀÇ °Ë»ç·®, »çÀü ºÐ¼® ¹× °í±Þ ¿°»ö Ç÷§ÆûÀÇ °³¹ß·Î ÀÎÇØ Å« ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2040³â±îÁö Àü ¼¼°è¿¡¼ ¾Ï ȯÀÚ°¡ 60% Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â Á¶Á÷ Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áõ°¡´Â Áø´Ü ÅøÀÇ °³¼±ÀÌ ¾ó¸¶³ª ½Ã±ÞÇÑÁö¸¦ Àß º¸¿©ÁÝ´Ï´Ù. ¾Ï Ä¡·áÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ Á¶Á÷ Áø´ÜÀÇ º¹À⼺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àü ¼¼°è ½ÇÇè½ÇÀÇ ±â¼ú ¹× ¿ª·® Çâ»ó¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è¿¡¼ ¿¹»óµÇ´Â ¾Ï ¹ßº´·ü Áõ°¡¸¦ °ü¸®Çϱâ À§Çؼ´Â Áö¿ª³» Áø´Ü ´É·ÂÀ» Çâ»ó½ÃŰ´Â °ÍÀÌ ÇʼöÀûÀ̸ç, ÀÌ´Â °Ë»ç ¼Ò¿ä ½Ã°£°ú Áø´Ü Á¤È®µµ¸¦ Çâ»ó½Ãų ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù.
Á¶Á÷ Áø´Ü »ê¾÷ÀÇ »çÀü ºÐ¼® ¿°»ö ½ÃÀåÀº ¿°»ö ±â¼úÀÇ ¹ßÀü, Â÷¼¼´ë ½ÃÄö½ÌÀ» °£¼ÒÈÇÏ´Â »çÀü ºÐ¼® Ç÷§Æû, ÀÚµ¿È ¿°»ö Ç÷§Æû, È¿À²¼º°ú ÀçÇö¼ºÀ» ÃËÁøÇÏ´Â °í󸮷® ½Ã½ºÅÛ µî ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Á¶Á÷ Áø´Ü ¾÷üµéÀº Á¶Á÷ Áø´ÜÀÇ Æ¯À̼º°ú ¹Î°¨µµ¸¦ ³ôÀÌ´Â Çõ½ÅÀûÀ̰í Áøº¸µÈ ½Ã½ºÅÛ ¹× ¿°»ö °³¹ß¿¡ Á¡Á¡ ´õ ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ƯÈ÷ ISH ¹× IHC¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, º´¸® °Ë»çÀÇ ÀϺο¡ CDx¸¦ Æ÷ÇÔÇϵµ·Ï Àǹ«ÈµÇ´Â ±ÔÁ¦, ¹ÙÀÌ¿À Á¦¾à ȸ»ç¿Í Áø´Ü ÀǾàǰ ȸ»ç¿ÍÀÇ Á¦ÈÞ Áõ°¡ µîÀÌ ±× ¹è°æÀÔ´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾Ï Áø´Ü ÀÎÇÁ¶ó ¼ºÀå, ¾Ï ¹ßº´·ü Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡, ÷´Ü Áø´Ü ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼º Áõ°¡, Á¤ºÎ Áö¿ø È®´ë µîÀº ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â ½ÃÀåÀ¸·Î ºÎ»óÇÏ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
¼¼°èÀÇ Á¶Á÷ Áø´Ü ¾÷°èÀÇ º¯¸ð
- ¿Ö ¼ºÀåÀÌ ¾î·Á¿öÁö°í Àִ°¡?
- The Strategic Imperative 8(TM)
- ¼¼°èÀÇ Á¶Á÷ Áø´Ü¾÷°è¿¡¼ Àü·«Àû Áß¿ä °úÁ¦ TOP 3ÀÇ ¿µÇâ
Á¶Á÷ Áø´Ü ¾÷°èÀÇ ¼ºÀå ȯ°æ - ¿¡ÄڽýºÅÛ
¼ºÀå ȯ°æ : ±â¾÷ÀÇ Çൿ
- °æÀï ȯ°æ
- ±â¼úº° ÁÖ¿ä °æÀï»ç
¼ºÀå ±âȸ ºÐ¼® : Á¶Á÷ Áø´Ü ¾÷°èÀÇ ¼ºÀå Á¦³Ê·¹ÀÌÅÍ
- ¼ºÀå ÁöÇ¥
- ¼ºÀå ÃËÁø¿äÀÎ
- ¼ºÀå ¾ïÁ¦¿äÀÎ
- Á¶Á÷ Áø´Ü ¾÷°èÀÇ µ¿Çâ
- ¿¹Ãø ¹æ¹ý°ú ÀüÁ¦Á¶°Ç
- ¸ÅÃâ°ú ¿¹Ãø
- ¸ÅÃâ°ú ¿¹Ãø ºÐ¼®
- ±â¼úº° ¸ÅÃâ ¿¹Ãø
- ÁÖ¿ä ¼ºÀå ±âȸ - Á¶Á÷ Áø´Ü ºÎ¹®
- Áö¿ªº° ¸ÅÃâ ¿¹Ãø
- Áö¿ªº° ¸ÅÃ⠺м® - NA
- Á¶Á÷ Áø´Ü ½ÃÀå ¿ªÇÐ - NA
- Áö¿ªº° ¸ÅÃ⠺м® - À¯·´
- Á¶Á÷ Áø´Ü ½ÃÀå ¿ªÇÐ - À¯·´
- Áö¿ªº° ¸ÅÃ⠺м® - APAC
- Á¶Á÷ Áø´Ü¾à ½ÃÀå ¿ªÇÐ - APAC
- Áö¿ªº° ¸ÅÃ⠺м® - MENASA¿Í ¶óƾ¾Æ¸Þ¸®Ä«
- ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ ¿¹Ãø
- ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃ⠺м®
- ¸ÅÃâ Á¡À¯À²
- ¸ÅÃâ Á¡À¯À² ºÐ¼®
- °æÀï ¸ÅÆ®¸¯½º
- ¼¼°èÀÇ Á¶Á÷ Áø´Ü ½ÃÀå - ÁÖ¸ñÇØ¾ß ÇÒ È°µ¿
- Á¶Á÷ Áø´ÜÀÇ ºñÁî´Ï½º ±âȸ¿Í Çõ½Å ·Îµå¸Ê
¼ºÀå ±âȸ ºÐ¼® : ºÐ¼®Àü ¿°»öÀÇ ¼ºÀå Á¦³Ê·¹ÀÌÅÍ
- ¼ºÀå ÁöÇ¥ - »çÀü ó¸® ¿°»ö
- ºÐ¼®Àü ¿°»öÀÇ ¸ÅÃâ ¿¹Ãø
- ºÐ¼®Àü ¿°»öÀÇ ¸ÅÃâ ¿¹Ãø ºÐ¼®
- ºÐ¼®Àü ¿°»öÀÇ ¸ÅÃâ ¿¹Ãø ºÐ¼®
¼ºÀå ±âȸ ºÐ¼® : ÷´Ü ¿°»öÀÇ ¼ºÀå Á¦³Ê·¹ÀÌÅÍ
- ¼ºÀå ÁöÇ¥ - ÷´Ü ¿°»ö
- ÷´Ü ¿°»ö ¸ÅÃâ ¿¹Ãø
- ÷´Ü ¿°»ö - ¸ÅÃâ ¿¹Ãø ºÐ¼®
- FDA ½ÂÀÎ Á¶Á÷ ±â¹Ý CDx ¸®½ºÆ®,2022-2023³â
¼ºÀå ±âȸ ºÐ¼® : ICP-APLISÀÇ ¼ºÀå Á¦³Ê·¹ÀÌÅÍ
- ¼ºÀå ÁöÇ¥ - ICP-APLIS
- ICP-APLISÀÇ ¸ÅÃâ ¿¹Ãø
- ICP-APLIS - ¸ÅÃâ ¿¹Ãø ºÐ¼®
- ICP-APLIS - ¸ÅÃâ ¿¹Ãø ºÐ¼®
¾×¼¼½º Á¦¾î ¼Ö·ç¼ÇÀÇ ¼ºÀå ±âȸ À¯´Ï¹ö½º
- ¼ºÀå ±âȸ 1 - ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ Á¶±â ½Äº°À» À§ÇÑ Á¾ÇÕ Áø´Ü ÆÐ³Î
- ¼ºÀå ±âȸ 2 - Á¤¹ÐÁø´ÜÀ» À§ÇÑ ¸ÖƼ¿À¹Í½º ºÐ¼®
- ¼ºÀå ±âȸ 3 - Á¶Á÷ ±â¹Ý µ¿¹ÝÁø´ÜÀ» À§ÇÑ µðÁöÅÐ º´¸®ÇÐ ±â´É
º£½ºÆ® ÇÁ·¢Æ¼½º ÀÎÁ¤
Frost Radar
´ÙÀ½ ½ºÅÜ
- ¼ºÀå ±âȸÀÇ ÀÌÁ¡°ú ¿µÇâ
- ´ÙÀ½ ½ºÅÜ
- µµÇ¥
- ¸éÃ¥»çÇ×
KSA
Companion Diagnostics-specific Advanced Staining and Multiomics Capabilities are Driving Market Growth
The global tissue diagnostics market will experience significant growth driven by the need for advanced staining in precise biomarker identification in personalized medicine, tissue biopsy test volumes, and pre-analytical and advanced staining platform development.
According to the WHO, there will be a 60% rise in cancer cases worldwide by 2040, which will fuel demand for tissue diagnostics. This increase highlights how urgently improved diagnostic tools are needed. The complexity of tissue diagnostics expanded due to advancements in cancer treatment, which require enhanced technology and capabilities in laboratories across the globe. Improving local diagnostic capacity is vital for managing the projected growth in cancer incidence worldwide, as it can improve test turnaround times and diagnostic accuracy-both of which substantially impact cancer treatment outcomes.
The pre-analytical staining market in the tissue diagnostics industry is being propelled by several key factors, such as growing advancements in staining technologies, pre-analytical platforms to simplify next-generation sequencing, automated staining platforms, and high-throughput systems to drive efficiency and reproducibility. Tissue diagnostics players are increasingly focusing on developing innovative and advanced systems and stains that enhance the specificity and sensitivity of tissue diagnostics. The advanced staining segment is the second leading segment due to a surge in adoption, especially driven by increased demand for ISH and IHC offerings, regulatory mandates to include CDx as part of pathology tests, and increased partnerships between biopharma companies and diagnostic companies.
Asia-Pacific's growing cancer diagnostics infrastructure, increasing cancer prevalence rate, rising healthcare spending, increasing access to advanced diagnostic technologies, and growing government support all contribute to the region being the fastest-growing market.
Table of Contents
Transformation in Global Tissue Diagnostics Industry
- Why is it Increasingly Difficult to Grow?
- The Strategic Imperative 8™
- The Impact of the Top 3 Strategic Imperatives on the Global Tissue Diagnostic Industry
Growth Environment-Ecosystem in Tissue Diagnostics Industry
- Scope of Analysis
- Segmentation
Growth Environment-Companies to Action
- Competitive Environment
- Key Competitor by Technology
Growth Opportunity Analysis-Growth Generator in Tissue Diagnostics Industry
- Growth Metrics
- Growth Drivers
- Growth Restraints
- Trends in the Tissue Diagnostics Industry
- Forecast Methodology and Assumptions
- Revenue Forecast
- Revenue Forecast Analysis
- Revenue Forecast by Technology
- Primary Growth Opportunities-Tissue Diagnostics Segments
- Revenue Forecast by Region
- Revenue Forecast Analysis by Region-NA
- Tissue Diagnostics Market Dynamics-NA
- Revenue Forecast Analysis by Region-Europe
- Tissue Diagnostics Market Dynamics-Europe
- Revenue Forecast Analysis by Region-APAC
- Tissue Diagnostics Market Dynamics-APAC
- Revenue Forecast Analysis by Region-MENASA & Latin America
- Revenue Forecast by End User
- Revenue Forecast Analysis by End User
- Revenue Share
- Revenue Share Analysis
- Competitor Matrix
- Global Tissue Diagnostics Market-Notable Activities
- Tissue Diagnostics Opportunity and Innovations Roadmap
Growth Opportunity Analysis-Growth Generator in Pre-Analytical Staining
- Growth Metrics-Pre-Analytical Staining
- Pre-analytical Staining Revenue Forecast
- Pre-analytical Staining Revenue Forecast Analysis
- Pre-analytical Staining Revenue Forecast Analysis
Growth Opportunity Analysis-Growth Generator in Advanced Staining
- Growth Metrics-Advance Staining
- Advanced Staining Revenue Forecast
- Advanced Staining-Revenue Forecast Analysis
- List of FDA-approved Tissue-based CDx, 2022-2023
Growth Opportunity Analysis-Growth Generator in ICP-APLIS
- Growth Metrics-ICP-APLIS
- ICP-APLIS Revenue Forecast
- ICP-APLIS-Revenue Forecast Analysis
- ICP-APLIS-Revenue Forecast Analysis
Growth Opportunity Universe in Access Control Solutions
- Growth Opportunity 1-Comprehensive Diagnostic Panels for Early Identification Of Cancer Biomarkers
- Growth Opportunity 2-Multiomics Analysis for Precision Diagnostics
- Growth Opportunity 3-Digital Pathology Capabilities for Tissue-based Companion Diagnostics
Best Practices Recognition
- Best Practices Recognition
Frost Radar
Next Steps
- Benefits and Impacts of Growth Opportunities
- Next Steps
- List of Exhibits
- Legal Disclaimer